CKS is no longer commissioned by the National Institute for Health and Clinical Excellence (NICE). NICE remains committed to providing a replacement service for CKS and is currently reviewing its options. In the meantime, although CKS content is now not being maintained, it still remains relevant and will continue to be made available. CKS content was generated under a programme of topic creation and update. To check if the topic you are viewing is current or out of date, please refer to the topic publication details by clicking on the 'How up-to-date is this topic?' link in the left hand menu on individual topic pages.
Corticosteroids - topical (skin), nose, and eyes
In the right clinical topic?
All ages
This CKS topic covers the management of people receiving topical corticosteroids, intranasal corticosteroids and corticosteroid eye preparations in primary care.
This CKS topic does not cover the management of the specific condition for which the person is receiving topical corticosteroids, intranasal corticosteroids and corticosteroid eye preparations. It also does not include information on drug doses.
For information on rectal corticosteroids, see the CKS topics on Crohn's disease and Ulcerative colitis.
For information on inhaled corticosteroids, see the CKS topics on Corticosteroids - inhaled, Asthma, and Chronic obstructive pulmonary disease.
The following CKS topics include information on the use of topical, intranasal, and intraocular corticosteroids:
- Topical corticosteroids
- Intranasal corticosteroids
- Intraocular corticosteroids should always be initiated in secondary care. Dosage information will therefore be provided by the specialist.
The target audience for this CKS topic is healthcare professionals working within the NHS in England, and providing first contact or primary health care.
CKS gratefully acknowledges the contribution of the British Association of Dermatologists in the development of this topic.
© NHS Institute for Innovation and Improvement